| 释义 |
- References
- Further reading
{{Infobox_gene}}Suppression of tumorigenicity 2 is a protein that in humans is encoded by the ST2 gene. [1] References 1. ^{{cite web| title = Entrez Gene: Suppression of tumorigenicity 2| url = https://www.ncbi.nlm.nih.gov/gene/6761| accessdate = 2018-07-12}}
Further reading {{refbegin | 2}}- {{cite journal |vauthors=Voloshyna I, Mucci T, Sher J, Fonacier LS, Littlefield MJ, Carsons S, Reiss AB |title=Plasma IL-33 in atopic patients correlates with pro-inflammatory cytokines and changes cholesterol transport protein expression: a surprising neutral overall impact on atherogenicity |journal=Clin. Exp. Allergy |volume=45 |issue=10 |pages=1554–65 |date=October 2015 |pmid=25703059 |doi=10.1111/cea.12516 |url=}}
- {{cite journal |vauthors=Yndart A, Kaushik A, Agudelo M, Raymond A, Atluri VS, Saxena SK, Nair M |title=Investigation of Neuropathogenesis in HIV-1 Clade B and C Infection Associated with IL-33 and ST2 Regulation |journal=ACS Chem Neurosci |volume=6 |issue=9 |pages=1600–12 |date=September 2015 |pmid=26110635 |doi=10.1021/acschemneuro.5b00156 |url=}}
- {{cite journal |vauthors=Miller WL, Saenger AK, Grill DE, Slusser JP, Bayes-Genis A, Jaffe AS |title=Prognostic Value of Serial Measurements of Soluble Suppression of Tumorigenicity 2 and Galectin-3 in Ambulatory Patients With Chronic Heart Failure |journal=J. Card. Fail. |volume=22 |issue=4 |pages=249–55 |date=April 2016 |pmid=26277907 |doi=10.1016/j.cardfail.2015.07.017 |url=}}
- {{cite journal |vauthors=Quick S, Waessnig NK, Kandler N, Poitz DM, Schoen S, Ibrahim K, Strasser RH, Speiser U |title=Soluble ST2 and myocardial fibrosis in 3T cardiac magnetic resonance |journal=Scand. Cardiovasc. J. |volume=49 |issue=6 |pages=361–6 |date=2015 |pmid=26287645 |doi=10.3109/14017431.2015.1076936 |url=}}
- {{cite journal |vauthors=Wang X, Zhu YF, Li DM, Qin Q, Wang Q, Muhali FS, Jiang WJ, Zhang JA |title=Polymorphisms of ST2-IL18R1-IL18RAP gene cluster: a new risk for autoimmune thyroid diseases |journal=Int. J. Immunogenet. |volume=43 |issue=1 |pages=18–24 |date=February 2016 |pmid=26566691 |doi=10.1111/iji.12240 |url=}}
- {{cite journal |vauthors=Katsarska O, Zaharieva E, Aneva N, Savova G, Stankova K, Boteva R |title=The soluble receptor ST2 is positively associated with occupational exposure to radiation |journal=Int. J. Radiat. Biol. |volume=92 |issue=2 |pages=87–93 |date=2016 |pmid=26634771 |doi=10.3109/09553002.2016.1115135 |url=}}
- {{cite journal |vauthors=Mathews LR, Lott JM, Isse K, Lesniak A, Landsittel D, Demetris AJ, Sun Y, Mercer DF, Webber SA, Zeevi A, Fischer RT, Feingold B, Turnquist HR |title=Elevated ST2 Distinguishes Incidences of Pediatric Heart and Small Bowel Transplant Rejection |journal=Am. J. Transplant. |volume=16 |issue=3 |pages=938–50 |date=March 2016 |pmid=26663613 |pmc=5078748 |doi=10.1111/ajt.13542 |url=}}
- {{cite journal |vauthors=Llibre C, Zamora E, Caballero À, Lupón J, Ros A, Benito N, de Antonio M, Galán A, Domingo M, Bayes-Genis A |title=The real-life value of ST2 monitoring during heart failure decompensation: impact on long-term readmission and mortality |journal=Biomarkers |volume=21 |issue=3 |pages=225–32 |date=2016 |pmid=26767401 |doi=10.3109/1354750X.2015.1130747 |url=}}
- {{cite journal |vauthors=Yu Q, Li XY, Cheng XD, Shen LP, Fang F, Zhang B, Hua H, Yan C, Tang RX, Zheng KY |title=Expression and potential roles of IL-33/ST2 in the immune regulation during Clonorchis sinensis infection |journal=Parasitol. Res. |volume=115 |issue=6 |pages=2299–305 |date=June 2016 |pmid=26944417 |doi=10.1007/s00436-016-4974-9 |url=}}
{{refend}}{{gene-stub}} |